Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Common Equity (2020 - 2025)

MDxHealth (MDXH) has disclosed Common Equity for 6 consecutive years, with -$12.1 million as the latest value for Q4 2025.

  • Quarterly Common Equity fell 181.49% to -$12.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$12.1 million through Dec 2025, down 181.49% year-over-year, with the annual reading at -$12.1 million for FY2025, 181.49% down from the prior year.
  • Common Equity hit -$12.1 million in Q4 2025 for MDxHealth, down from $14.8 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $46.9 million in Q4 2021 to a low of -$12.1 million in Q4 2025.
  • Historically, Common Equity has averaged $13.2 million across 5 years, with a median of $9.3 million in 2022.
  • Biggest five-year swings in Common Equity: soared 701.83% in 2021 and later crashed 181.49% in 2025.
  • Year by year, Common Equity stood at $46.9 million in 2021, then tumbled by 80.14% to $9.3 million in 2022, then dropped by 22.62% to $7.2 million in 2023, then soared by 105.9% to $14.8 million in 2024, then crashed by 181.49% to -$12.1 million in 2025.
  • Business Quant data shows Common Equity for MDXH at -$12.1 million in Q4 2025, $14.8 million in Q4 2024, and $7.2 million in Q4 2023.